Pfizer’s contraceptive injectable drug Depo-Provera has come under intensified scrutiny after some studies have linked the pharmaceutical’s active ingredient medroxyprogesterone acetate, may increase the risk of developing brain tumors, particularly meningiomas. The recent lawsuits allege that the drug’s manufacturer knew or should have known about this risk but did not warn consumers or healthcare providers.
In the United States, thousands of women use the injectable drug as their birth control method. As a result, these women may be at increased risk for brain tumors and the likelihood of many more lawsuits against the manufacturer Pfizer is anticipated. If the numbers warrant, an MDL (multidistrict litigation) will be formed in order to more efficiently handle the potentially thousands of cases.
Symptoms of meningiomas include headaches, vision problems, seizures, and other neurological issues. These symptoms have the potential to cause severe disability, permanent impairment, or life-threatening conditions. Meningiomas are the most common type of brain tumor, accounting for 30% of all diagnosed brain tumors, according to Johns Hopkins. These tumors originate in the meninges, which are the outer three layers of tissue between the skull and the brain that cover and protect the brain just under the skull.
Meningiomas are a serious medical condition that require immediate medical intervention. If you or a loved one are using Depo-Provera and are experiencing any of the above-mentioned symptoms, consult with a neurologist immediately. If you are injured by Depo-Provera, please contact me immediately for a free initial consultation.
